Immunotherapy for the First-Line Treatment of Patients with Metastatic Non–Small Cell Lung Cancer
Year: 2019
Type: review
Source: Clinical Cancer Research
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: immunotherapy, metastatic non-small cell lung cancer, first-line therapy, PD-1 inhibitors, PD-L1 inhibitors, CTLA-4 inhibitors, immune checkpoint inhibitors, PD-L1 expression, tumor mutational burden, EGFR mutation, ALK mutations, tyrosine kinase inhibitors, combination chemotherapy, treatment decision-making
Open Access status: closed
Funder: MedImmune
OpenAlex ID: W2910971690
